Young Paul J, Al-Fares Abdulrahman, Aryal Diptesh, Arabi Yaseen M, Ashraf Muhammad Sheharyar, Bagshaw Sean M, Beane Abigail, de Oliveira Manoel Airton L, Dullawe Layoni, Fazla Fathima, Fujii Tomoko, Haniffa Rashan, Hasan Mohd Shahnaz, Hodgson Carol L, Hunt Anna, Lawrence Cassie, Maia Israel Silva, Mackle Diane, Monti Giacomo, Nichol Alistair D, Olatunji Shaanti, Patodia Sristi, Rashan Aasiyah, Rashan Sumayyah, Kasza Jessica
Intensive Care Unit, Wellington Hospital, Wellington, New Zealand.
Medical Research Institute of New Zealand, Wellington, New Zealand.
Crit Care Resusc. 2024 Jun 21;26(2):87-94. doi: 10.1016/j.ccrj.2024.03.004. eCollection 2024 Jun.
The effect of conservative vs. liberal oxygen therapy on 90-day in-hospital mortality in adults with hypoxic ischaemic encephalopathy (HIE) following a cardiac arrest who are receiving invasive mechanical ventilation in the intensive care unit (ICU) is uncertain.
To summarise the protocol and statistical analysis plan for the Mega-ROX HIE trial.
Mega-ROX HIE is an international randomised clinical trial that will be conducted within an overarching 40,000-participant registry-embedded clinical trial comparing conservative and liberal ICU oxygen therapy regimens. We expect to enrol approximately 4000 participants with suspected HIE following a cardiac arrest who are receiving invasive mechanical ventilation in the ICU.
The primary outcome is in-hospital all-cause mortality up to 90 days from the date of randomisation. Secondary outcomes include duration of survival, duration of mechanical ventilation, ICU length of stay, hospital length of stay, and the proportion of participants discharged home.
Mega-ROX HIE will compare the effect of conservative vs. liberal oxygen therapy regimens on day-90 in-hospital mortality in adults in the ICU with suspected HIE following a cardiac arrest. The protocol and planned analyses are reported here to mitigate analysis bias.
Australian and New Zealand Clinical Trials Registry (ACTRN 12620000391976).
对于在重症监护病房(ICU)接受有创机械通气的心脏骤停后发生缺氧缺血性脑病(HIE)的成年人,保守氧疗与宽松氧疗对90天院内死亡率的影响尚不确定。
总结Mega-ROX HIE试验的方案和统计分析计划。
设计、设置与参与者:Mega-ROX HIE是一项国际随机临床试验,将在一项包含40000名参与者的总体注册嵌入式临床试验中进行,该试验比较保守和宽松的ICU氧疗方案。我们预计招募约4000名心脏骤停后疑似HIE且在ICU接受有创机械通气的参与者。
主要结局是自随机分组之日起90天内的院内全因死亡率。次要结局包括生存时间、机械通气时间、ICU住院时间、住院时间以及出院回家的参与者比例。
Mega-ROX HIE将比较保守与宽松氧疗方案对ICU中疑似心脏骤停后发生HIE的成年人90天院内死亡率的影响。本文报告了方案和计划分析,以减少分析偏倚。
澳大利亚和新西兰临床试验注册中心(ACTRN 12620000391976)。